Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0406256 on March 5, 2007

Published online before print March 5, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0406256v1
81/6/1523    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burelout, C.
Right arrow Articles by Bourgoin, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burelout, C.
Right arrow Articles by Bourgoin, S. G.
(Journal of Leukocyte Biology. 2007;81:1523-1534.)
© 2007 by Society for Leukocyte Biology

Dissociation between the translocation and the activation of Akt in fMLP-stimulated human neutrophils—effect of prostaglandin E2

Chantal Burelout*, Paul H. Naccache*,{dagger} and Sylvain G. Bourgoin*,{ddagger},1

* Centre de Recherche en Rhumatologie-Immunologie, Centre de Recherche du CHUL, and Départements de
{dagger} Médecine et
{ddagger} d’Anatomie-Physiologie, Université Laval, Québec, Canada

1 Correspondence: Centre de Recherche en Rhumatologie-Immunologie, Centre de Recherche du CHUL, 2705 Boul. Laurier, Room T1-49, Sainte-Foy, Québec, Canada G1V 4G2. E-mail: sylvain.bourgoin{at}crchul.ulaval.ca

PGE2 and other cAMP-elevating agents are known to down-regulate most functions stimulated by fMLP in human polymorphonuclear neutrophils. We reported previously that the inhibitory potential of PGE2 resides in its capacity to suppress fMLP-stimulated PI-3K{gamma} activation via the PGE2 receptor EP2 and hence, to decrease phosphatidylinositol 3,4,5-triphosphate [PI(3,4,5)P3] formation. Akt activity is stimulated by fMLP through phosphorylation on threonine 308 (Thr308) and serine 473 (Ser473) by 3-phosphoinositide-dependent kinase 1 (PDK1) and MAPK-AP kinase (APK)-APK-2 (MAPKAPK-2), respectively, in a PI-3K-dependent manner. Despite the suppression of fMLP-induced PI-3K{gamma} activation observed in the presence of PGE2, we show that Akt is fully phosphorylated on Thr308 and Ser473. However, fMLP-induced Akt translocation is decreased markedly in this context. PGE2 does not affect the phosphorylation of MAPKAPK-2 but decreases the translocation of PDK1 induced by fMLP. Other cAMP-elevating agents such as adenosine (Ado) similarly block the fMLP-induced PI-3K{gamma} activation process but do not inhibit Akt phosphorylation. However, Akt activity stimulated by fMLP is down-regulated slightly by agonists that elevate cAMP levels. Whereas protein kinase A is not involved in the maintenance of Akt phosphorylation, it is required for the inhibition of Akt translocation by PGE2. Moreover, inhibition of fMLP-stimulated PI-3K{delta} activity by the selective inhibitor IC87114 only partially affects the late phase of Akt phosphorylation in the presence of PGE2. Taken together, these results suggest that cAMP-elevating agents, such as PGE2 or Ado, are able to induce an alternative mechanism of Akt activation by fMLP in which the translocation of Akt to PI(3,4,5)P3-enriched membranes is not required prior to its phosphorylation.

Key Words: cAMP • PI-3K • adenosine




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
N. El Zein, B. Badran, and E. Sariban
VIP differentially activates {beta}2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1
J. Leukoc. Biol., April 1, 2008; 83(4): 972 - 981.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Leukocyte Biology.